Alliance A031501: Phase III randomized adjuvant study of MK-3475 (pembrolizumab) in muscle-invasive and locally advanced urothelial carcinoma (MIBC) (AMBASSADOR) versus observation Meeting Abstract


Authors: Apolo, A. B.; Rosenberg, J. E.; Kim, W. Y.; Chen, R. C.; Sonpavde, G.; Srinivas, S.; Mortazavi, A.; Watt, C.; Mallek, M.; Graap, K.; Diaz, C.; Odegaard, M.; Ballman, K. V.; Morris, M. J.
Abstract Title: Alliance A031501: Phase III randomized adjuvant study of MK-3475 (pembrolizumab) in muscle-invasive and locally advanced urothelial carcinoma (MIBC) (AMBASSADOR) versus observation
Meeting Title: 2019 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 7 Suppl.
Meeting Dates: 2019 Feb 14-16
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-03-01
Language: English
ACCESSION: WOS:000489108800037
DOI: 10.1200/JCO.2019.37.7_suppl.TPS504
PROVIDER: wos
Notes: Meeting Abstract: TPS504 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Morris
    577 Morris
  2. Jonathan Eric Rosenberg
    510 Rosenberg